Faes Farma continued its stellar form into the second quarter, with Q2 results coming slightly ahead of our otherwise optimistic expectations. Revenue increased c.10% to €53.7m (up c.9% in H1 to €105m), driven by growth across all business areas (including animal nutrition and the pharmaceutical business in both international and domestic markets). The domestic market performance continued to strengthen (7.8% growth vs just 0.1% for the sector) with new releases (apart from their fl
03 Aug 2015
Strong results driven by broad-based growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong results driven by broad-based growth
Faes Farma, S.A. (FFEA:FRA) | 0 0 2.0% | Mkt Cap: 765.7m
- Published:
03 Aug 2015 -
Author:
Jyoti Prakash - Pages:
Faes Farma continued its stellar form into the second quarter, with Q2 results coming slightly ahead of our otherwise optimistic expectations. Revenue increased c.10% to €53.7m (up c.9% in H1 to €105m), driven by growth across all business areas (including animal nutrition and the pharmaceutical business in both international and domestic markets). The domestic market performance continued to strengthen (7.8% growth vs just 0.1% for the sector) with new releases (apart from their fl